SciELO - Scientific Electronic Library Online

 
vol.37 número4Mortalidad por enfermedades cerebrovasculars en Colombia: 30 años de observaciónLipofuscinosis ceroidea neuronal 6 (enfermedad Kufs tipo A): Reporte de caso en Colombia índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Acta Neurológica Colombiana

versión impresa ISSN 0120-8748versión On-line ISSN 2422-4022

Resumen

MARTINEZ-VILLOTA, Viviana Alexandra  y  PORTILLO MINO, José Dario. Thrombolysis for ischemic stroke in a reference hospital in Nariño - Colombia. Acta Neurol Colomb. [online]. 2021, vol.37, n.4, pp.189-196.  Epub 03-Dic-2021. ISSN 0120-8748.  https://doi.org/10.22379/24224022387.

INTRODUCTION:

Stroke is the second leading cause of death and third of disability in the world. Intravenous Thrombolysis as a treatment for acute ischemic stroke has been shown to reduce disability and mortality; however, it is directly linked to administration time and adequate stroke care attention. Through this work, the times of attention in thrombolysis are evaluated at the Hospital Universitario Departamental de Narino E.S.E, as a local reference institution in Colombia.

METHODS:

A retrospective descriptive study included patients with ischemic stroke who received intravenous thrombolysis between 2014 and 2019. The analysis was performed using descriptive statistics and absolute and relative frequencies. To assess the differences, it was divided into three attention periods.

RESULTS:

50 patients were evaluated, with an average age of 67.6 years, 58% men. In 70% a decrease greater than 3 NIHSS points was observed post-thrombolysis. The 58% had mRS 0-1. There was a difference between the medians in the Door-CT time with 36.5 (n = 10, 2014-2015), 34.5 (n = 16, 2016-2017) and 16 minutes (n = 24, 2018-2019). And in the Door-Needle time was 154.8; 98.2 and 79.9 minutes in the same periods. In 45.8%, the Door-Needle time was less than 60 minutes in the third period.

CONCLUSIONS:

There is evidence of an increase in the number of patients receiving intravenous thrombolysis throughout the years evaluated, as well as a decrease in Door-CT and Door-Needle times, as markers of improvement in clinical care.

Palabras clave : Stroke; Thrombolytic Therapy; Developing Countries; Tissue Plasminogen Activator; Quality of Health Care; Quality Indicators, Health Care.(MeSH).

        · resumen en Español     · texto en Español     · Español ( pdf )